Ubiquitination status does not affect Vps34 degradation
返回论文页
|更新时间:2022-06-24
|
Ubiquitination status does not affect Vps34 degradation
Genes & DiseasesVol. 7, Issue 3, (2020)
作者机构:
1. Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, 1 Youyi Road,Chongqing,China,400016
2. Department of Physiology, Wayne State University School of Medicine,MI,Detroit,USA,48201
Jing Tang, Fei Sun, Xiao-Juan Deng, et al. Ubiquitination status does not affect Vps34 degradation. [J]. Genes & Diseases 7(3).(2020)
DOI:
Jing Tang, Fei Sun, Xiao-Juan Deng, et al. Ubiquitination status does not affect Vps34 degradation. [J]. Genes & Diseases 7(3).(2020) DOI: 10.1016/j.gendis.2019.05.003.
Ubiquitination status does not affect Vps34 degradation
摘要
Abstract
Vps34 (vacuolar protein-sorting 34) plays important role in autophagy and endosomal trafficking. These processes are closely associated protein ubiquitination and degradation. We have hypothesized that Vps34 ubiquitination status would also control its degradation. Here
we report that our results did not support this assumption. In cells transiently transfected with ubiquitin (UB) constructs contained different lysine residues (Ks)
Vps34 ubiquitination could occur regardless of the presence of any Ks in UB. However
Vps34 protein levels were not significantly altered in cells transiently transfected with these UB mutants. We further found that Vps34 protein was altered by pharmacological manipulation of E2/E3 activity; yet this effect was not significantly affected by UB overexpression. In vivo experiments revealed that in APP/PS1 mice
an animal model of Alzheimer's disease (AD)
although ubiquitination of Vps34 was significantly reduced
Vps34 protein levels remained unchanged. Vps34 indeed was subjected to proteasomal or lysosomal degradation
as prolonged treatment of proteasomal inhibitor MG132 or lysosomal inhibitor chloroquine elevated Vps34 protein levels. We conclude that unlike most of other proteins
Vps34 ubiquitination is not closely associated with its degradation.
E674Q (Shanghai APP mutant), a novel amyloid precursor protein mutation, in familial late-onset Alzheimer's disease
Emerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
Chondroitin Polymerizing Factor (CHPF) promotes cell proliferation and tumor growth in human osteosarcoma by inhibiting SKP2's ubiquitination while activating the AKT pathway
PRMT1 promotes the proliferation and metastasis of gastric cancer cells by recruiting MLXIP for the transcriptional activation of the β-catenin pathway
Genetic profiles of familial late-onset Alzheimer's disease in China: The Shanghai FLOAD study
Related Author
Gang Wang
Yongfang Zhang
Xinyi Xie
Boyu Chen
Lina Pan
Jianping Li
Wanbing Wang
Jintao Wang
Related Institution
Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine
Shenzhen Research Institute of Xiamen University
Department of Medicinal Chemistry, School of Pharmacy, Fudan University
Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University
Department of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine